Skip to main content

sec filings

Insider trades

Open-market buys and sales that company insiders report to the SEC on .

Side
Planned sales
Role
RPRX

Updated 10/6/2026, 11:12 AM ET.

RPRX

Royalty Pharma plc

Sale$235,595

Urist Marshall

EVP, Research & Investments

4,126 shat $57.10Filed Oct 5, 5:12 PM ET
Filing
RPRX

Royalty Pharma plc

Sale$238,813

Urist Marshall

EVP, Research & Investments

4,126 shat $57.88Filed Sep 30, 4:32 PM ET
Filing
RPRX

Royalty Pharma plc

Sale$5,853,095

Hite Christopher

EVP & Chairman, Partnering

100,000 shat $58.53Filed Sep 24, 4:10 PM ET
Filing
RPRX

Royalty Pharma plc

Sale$5,997,250

Hite Christopher

EVP & Chairman, Partnering

100,000 shat $59.97Filed Aug 19, 4:20 PM ET
Filing
RPRX

Royalty Pharma plc

Sale$645,551

Coyne Terrance P.

EVP & CFO

11,002 shat $58.68Filed Aug 17, 5:01 PM ET
Filing

Read from public SEC filings. Not financial advice.